Cardiovascular toxicity of nicotine: Implications for electronic cigarette use

Trends Cardiovasc Med. 2016 Aug;26(6):515-23. doi: 10.1016/j.tcm.2016.03.001. Epub 2016 Mar 10.

Abstract

The cardiovascular safety of nicotine is an important question in the current debate on the benefits vs. risks of electronic cigarettes and related public health policy. Nicotine exerts pharmacologic effects that could contribute to acute cardiovascular events and accelerated atherogenesis experienced by cigarette smokers. Studies of nicotine medications and smokeless tobacco indicate that the risks of nicotine without tobacco combustion products (cigarette smoke) are low compared to cigarette smoking, but are still of concern in people with cardiovascular disease. Electronic cigarettes deliver nicotine without combustion of tobacco and appear to pose low-cardiovascular risk, at least with short-term use, in healthy users.

Keywords: Cardiovascular disease; Cigarette smoking; Electronic cigarettes; Nicotine.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Inhalation
  • Animals
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / pathology
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular System / drug effects*
  • Cardiovascular System / pathology
  • Cardiovascular System / physiopathology
  • Consumer Product Safety
  • Electronic Nicotine Delivery Systems / adverse effects*
  • Humans
  • Nicotine / administration & dosage
  • Nicotine / adverse effects*
  • Nicotine / pharmacokinetics
  • Nicotinic Agonists / administration & dosage
  • Nicotinic Agonists / adverse effects*
  • Nicotinic Agonists / pharmacokinetics
  • Risk Assessment
  • Risk Factors
  • Smoking / adverse effects
  • Smoking Cessation / methods*
  • Smoking Prevention*
  • Time Factors
  • Vaping / adverse effects*

Substances

  • Nicotinic Agonists
  • Nicotine